|
Volumn 1349, Issue 3, 1997, Pages 264-274
|
Modification of heart sarcolemmal phosphoinositide pathway by lysophosphatidylcholine
|
Author keywords
Cardiac sarcolemma; Diabetes; Ischemia reperfusion; Lysophosphatidylcholine; Phosphatidylinositol kinase; Phosphoinositide phospholipase C
|
Indexed keywords
INSULIN ZINC SUSPENSION;
LYSOPHOSPHATIDYLCHOLINE;
PHOSPHATIDYLINOSITIDE;
PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;
PHOSPHATIDYLINOSITOL KINASE;
ACUTE HEART INFARCTION;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CARDIOMYOPATHY;
CONTROLLED STUDY;
DIABETES MELLITUS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HEART MUSCLE FIBER MEMBRANE;
MALE;
NONHUMAN;
PHOSPHOLIPID METABOLISM;
PRIORITY JOURNAL;
RAT;
SARCOLEMMA;
SECOND MESSENGER;
STREPTOZOCIN DIABETES;
SUBCUTANEOUS DRUG ADMINISTRATION;
1-PHOSPHATIDYLINOSITOL 4-KINASE;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
CALCIUM;
DIABETES MELLITUS, EXPERIMENTAL;
HEART;
LYSOPHOSPHATIDYLCHOLINES;
MALE;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE;
PHOSPHATIDYLINOSITOLS;
PHOSPHOLIPASE C;
PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);
PLASMALOGENS;
RATS;
RATS, SPRAGUE-DAWLEY;
SARCOLEMMA;
SIGNAL TRANSDUCTION;
STRUCTURE-ACTIVITY RELATIONSHIP;
ANIMALIA;
|
EID: 0031592219
PISSN: 00052760
EISSN: None
Source Type: Journal
DOI: 10.1016/S0005-2760(97)00142-2 Document Type: Article |
Times cited : (23)
|
References (53)
|